跳至主要内容
临床试验/NCT01070810
NCT01070810已完成1 期

Thiamine as a Metabolic Resuscitator in Septic Shock

Beth Israel Deaconess Medical Center1 个研究点 分布在 1 个国家目标入组 88 人开始时间: 2010年2月最近更新:
适应症
干预措施

试验速览

阶段
1 期
状态
已完成
入组人数
88
试验地点
1
主要终点
Lactate Level 24 Hours After the First Study Medication Dose

研究概览

简要总结

The major goal of this project is to determine whether the use of thiamine in patients with septic shock will result in attenuation of lactic acidosis and a more rapid reversal of shock.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Greater than 18 years old
  • Suspected or confirmed source of infection
  • Hypotension (systolic pressure <90 mmHg) after a minimum 2 liter fluid bolus followed by vasopressor-dependence.
  • Lactic Acidosis > 3 mmol/dl

排除标准

  • Competing cause of lactic acidosis including: seizures within 3 hours of enrollment, use of linazolid metformin or anti-retrovirals at the time of enrollment, carbon monoxide or cyanide poisoning, highly suspected or known ischemic bowel, and known mitochondrial disorders
  • Liver dysfunction specifically defined as AST or ALT elevation greater than 240
  • Current Thiamine supplements or usage
  • Competing indication for thiamine administration
  • Cardiac Arrest
  • DNR/DNI or comfort care status (DNR status in an intubated patient receiving full care is eligible)

研究组 & 干预措施

1

Placebo Comparator

50 ml D5W

干预措施: D5W (Drug)

2

Experimental

200mg Thiamine in 50ml D5W

干预措施: Thiamine (Drug)

结局指标

主要结局

Lactate Level 24 Hours After the First Study Medication Dose

时间窗: 24 hours

次要结局

  • APACHE II Score at 24 Hours(24 hours)
  • Number of Participants With Shock Reversal(Hospital stay, average 2 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Michael Donnino

Michael W. Donnino, MD

Beth Israel Deaconess Medical Center

研究点 (1)

Loading locations...

相似试验